Anti‐inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial

[1]  A. Tam,et al.  Efficacy of Clarithromycin‐Naproxen‐Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open‐label Randomized, Controlled, Phase IIb/III Trial , 2017, Chest.

[2]  F. Hsiao,et al.  Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study , 2017, The Journal of infectious diseases.

[3]  D. Hui,et al.  Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infections. , 2016, International journal of antimicrobial agents.

[4]  A. Garg,et al.  Macrolide antibiotics and the risk of ventricular arrhythmia in older adults , 2016, Canadian Medical Association Journal.

[5]  M. Cabana,et al.  Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. , 2015, JAMA.

[6]  Christine E. Becker,et al.  Influenza virus-induced lung injury: pathogenesis and implications for treatment , 2015, European Respiratory Journal.

[7]  P. Foster,et al.  Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma , 2015, Thorax.

[8]  Catherine S. K. Cheung,et al.  Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients , 2015, European Respiratory Journal.

[9]  K. Schmetterer,et al.  Azithromycin suppresses CD4+ T-cell activation by direct modulation of mTOR activity , 2014, Scientific Reports.

[10]  F. Hayden,et al.  Antiviral combinations for severe influenza , 2014, The Lancet Infectious Diseases.

[11]  H. Kubo,et al.  Additional treatment with clarithromycin reduces fever duration in patients with influenza. , 2014, Respiratory investigation.

[12]  G. Verleden,et al.  Azithromycin: mechanisms of action and their relevance for clinical applications. , 2014, Pharmacology & therapeutics.

[13]  M. Fine,et al.  Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. , 2014, JAMA.

[14]  K. Yanagihara,et al.  Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study , 2014, PloS one.

[15]  M. Ison.  Adjuvant immunosuppression in the management of severe influenza: friend or foe? , 2014, Critical care medicine.

[16]  E. R. Sutherland,et al.  Designing clinical trials to address the needs of childhood and adult asthma: the National Heart, Lung, and Blood Institute's AsthmaNet. , 2014, The Journal of allergy and clinical immunology.

[17]  F. Hayden,et al.  A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  H. Kido,et al.  Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis , 2013, PloS one.

[19]  D. Hui,et al.  Adjunctive therapies and immunomodulatory agents in the management of severe influenza , 2013, Antiviral Research.

[20]  S. Wong,et al.  Role of human Toll‐like receptors in naturally occurring influenza A infections , 2013, Influenza and other respiratory viruses.

[21]  Semicyuc,et al.  Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia , 2013, Intensive Care Medicine.

[22]  A. Coleman.  Macrolide Antibiotics and Survival in Patients with Acute Lung Injury , 2012 .

[23]  T. Marrie,et al.  Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Y. Jang,et al.  Macrolide Therapy in Respiratory Viral Infections , 2012, Mediators of inflammation.

[25]  Yoko Ito,et al.  Innate Immune Response of Human Alveolar Macrophages during Influenza A Infection , 2012, PloS one.

[26]  H. Mukae,et al.  Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection. , 2012, The Journal of infection.

[27]  D. Hui,et al.  Cytokine Response Patterns in Severe Pandemic 2009 H1N1 and Seasonal Influenza among Hospitalized Adults , 2011, PloS one.

[28]  D. Hui,et al.  Dexamethasone in community-acquired pneumonia , 2011, The Lancet.

[29]  E. Cordero,et al.  Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. , 2011, The Journal of infection.

[30]  J. Sung,et al.  Viral Clearance and Inflammatory Response Patterns in Adults Hospitalized for Pandemic 2009 Influenza A(H1N1) Virus Pneumonia , 2011, Antiviral therapy.

[31]  B. Rubin,et al.  Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications , 2010, Clinical Microbiology Reviews.

[32]  J. Rello,et al.  Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza , 2009, Critical care.

[33]  J. Alcorn,et al.  Critical Role of IL-17RA in Immunopathology of Influenza Infection , 2009, The Journal of Immunology.

[34]  Carole R. Baskin,et al.  Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus , 2009, Proceedings of the National Academy of Sciences.

[35]  J. Sung,et al.  Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  J. Tang,et al.  Rapid Multiplex Nested PCR for Detection of Respiratory Viruses , 2007, Journal of Clinical Microbiology.

[37]  G. Verleden,et al.  Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. , 2006, American journal of respiratory and critical care medicine.

[38]  G. Verleden,et al.  Azithromycin reduces airway neutrophilia in patients with bronchiolitis obliterans syndrome , 2005 .

[39]  F. Fraschini,et al.  Effect of Multiple Doses of Clarithromycin and Amoxicillin on IL-6, IFNγ and IL-10 Plasma Levels in Patients with Community Acquired Pneumonia , 2004, Journal of chemotherapy.

[40]  T. Fukui,et al.  Effect of maclorides on duration and resolution of symptoms and complication of pneumonia in children with influenza. , 2002, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[41]  D. Baldwin,et al.  Azithromycin concentrations at the sites of pulmonary infection. , 1990, The European respiratory journal.